22 results found on lung cancer
Select a condition to view medications used to treat that condition
- malignant neoplasm of lung
- prevention of chemotherapy-induced myelosuppression in extensive-stage small cell lung cancer
- PD-L1 positive non-small cell lung cancer
- EGFR T790M mutation-positive non-small cell lung cancer
- metastatic non-small cell lung cancer with EGFR exon 21 L858R substitution mutation
- PD-L1 positive, EGFR-negative, ALK-negative, ROS1-negative non-small cell lung cancer
- EGFR negative, ALK negative, non-small cell lung cancer
- metastatic non-small cell lung cancer with EGFR exon 19 deletion
- non-small cell lung cancer with EGFR exon 21 L858R substitution mutation
- PD-L1 positive, EGFR-negative, ALK-negative metastatic non-small cell lung cancer
- non-small cell lung cancer
- nonsquamous non-small cell lung cancer
- extensive-stage small cell lung cancer
- anaplastic lymphoma kinase positive non-small cell lung cancer
- ROS1 positive non-small cell lung cancer
- non-small cell lung cancer with BRAF V600E mutation
- epidermal growth factor receptor positive non-small cell lung cancer
- RET fusion-positive metastatic non-small cell lung cancer
- non-small cell lung cancer with EGFR exon 19 deletion
- non-small cell lung cancer with mesenchymal-epithelial transition (MET) exon 14 skipping
View More
- malignant neoplasm of lung
- prevention of chemotherapy-induced myelosuppression in extensive-stage small cell lung cancer
- PD-L1 positive non-small cell lung cancer
- EGFR T790M mutation-positive non-small cell lung cancer
- metastatic non-small cell lung cancer with EGFR exon 21 L858R substitution mutation
- PD-L1 positive, EGFR-negative, ALK-negative, ROS1-negative non-small cell lung cancer
- EGFR negative, ALK negative, non-small cell lung cancer
- metastatic non-small cell lung cancer with EGFR exon 19 deletion
- non-small cell lung cancer with EGFR exon 21 L858R substitution mutation
- PD-L1 positive, EGFR-negative, ALK-negative metastatic non-small cell lung cancer
View More